Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome c oxidase assembly factor 6 is a mitochondrial protein encoded by the COA6 gene and is integral to the biogenesis of cytochrome c oxidase (Complex IV) in the electron transport chain. Located in the intermembrane space, COA6 facilitates copper delivery, stabilizes newly formed COX2, and supports mitochondrial oxidative phosphorylation. Mutations in COA6 lead to severe mitochondrial diseases, including fatal infantile cardioencephalomyopathy, and its upregulation is associated with poor prognosis in several cancers, indicating its biomarker and therapeutic target potential[1][2][3][4][5][6][7].
Not fully established for drugs. COA6 functions by aiding copper transfer and stabilizing COX2 in Complex IV assembly; modulating its expression affects mitochondrial respiration and cell proliferation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome c oxidase assembly factor 6 (COA6).